Why Is Turn Therapeutics Stock Soaring Over 370% Premarket Today?
The stock’s debut on Wednesday followed the SEC’s approval of its registration statement on Sept. 30, clearing the way for its public listing as it advances late-stage clinical programs in eczema and onychomycosis.